nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ABCB1—esophageal cancer	0.469	1	CbGaD
Mirabegron—BCHE—Cisplatin—esophageal cancer	0.167	0.427	CbGbCtD
Mirabegron—SLCO1A2—Methotrexate—esophageal cancer	0.102	0.26	CbGbCtD
Mirabegron—ALB—Methotrexate—esophageal cancer	0.0525	0.134	CbGbCtD
Mirabegron—ABCB1—Cisplatin—esophageal cancer	0.0423	0.108	CbGbCtD
Mirabegron—ABCB1—Methotrexate—esophageal cancer	0.0274	0.0703	CbGbCtD
Mirabegron—BCHE—diaphragm—esophageal cancer	0.00245	0.471	CbGeAlD
Mirabegron—Rash macular—Capecitabine—esophageal cancer	0.00184	0.0415	CcSEcCtD
Mirabegron—Joint swelling—Capecitabine—esophageal cancer	0.00154	0.0347	CcSEcCtD
Mirabegron—Infection—Carboplatin—esophageal cancer	0.00124	0.0279	CcSEcCtD
Mirabegron—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.00115	0.0258	CcSEcCtD
Mirabegron—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000758	0.0171	CcSEcCtD
Mirabegron—Blood pressure increased—Capecitabine—esophageal cancer	0.000755	0.017	CcSEcCtD
Mirabegron—Dry eye—Capecitabine—esophageal cancer	0.000697	0.0157	CcSEcCtD
Mirabegron—Neoplasm—Capecitabine—esophageal cancer	0.000682	0.0154	CcSEcCtD
Mirabegron—Breast disorder—Cisplatin—esophageal cancer	0.000671	0.0151	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000669	0.0151	CcSEcCtD
Mirabegron—Nasopharyngitis—Cisplatin—esophageal cancer	0.000664	0.015	CcSEcCtD
Mirabegron—Vascular purpura—Capecitabine—esophageal cancer	0.000612	0.0138	CcSEcCtD
Mirabegron—Atrial fibrillation—Capecitabine—esophageal cancer	0.000578	0.013	CcSEcCtD
Mirabegron—Purpura—Capecitabine—esophageal cancer	0.000568	0.0128	CcSEcCtD
Mirabegron—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000559	0.0126	CcSEcCtD
Mirabegron—Cystitis noninfective—Methotrexate—esophageal cancer	0.000549	0.0124	CcSEcCtD
Mirabegron—Osteoarthritis—Capecitabine—esophageal cancer	0.000548	0.0124	CcSEcCtD
Mirabegron—Cystitis—Methotrexate—esophageal cancer	0.000542	0.0122	CcSEcCtD
Mirabegron—Vaginal infection—Methotrexate—esophageal cancer	0.00053	0.012	CcSEcCtD
Mirabegron—Urinary retention—Capecitabine—esophageal cancer	0.000521	0.0117	CcSEcCtD
Mirabegron—Neoplasm—Methotrexate—esophageal cancer	0.000508	0.0115	CcSEcCtD
Mirabegron—Bladder pain—Methotrexate—esophageal cancer	0.000508	0.0115	CcSEcCtD
Mirabegron—Urinary tract disorder—Cisplatin—esophageal cancer	0.000508	0.0115	CcSEcCtD
Mirabegron—Connective tissue disorder—Cisplatin—esophageal cancer	0.000505	0.0114	CcSEcCtD
Mirabegron—Urethral disorder—Cisplatin—esophageal cancer	0.000504	0.0114	CcSEcCtD
Mirabegron—Breast disorder—Capecitabine—esophageal cancer	0.000495	0.0112	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000493	0.0111	CcSEcCtD
Mirabegron—Nasopharyngitis—Capecitabine—esophageal cancer	0.00049	0.011	CcSEcCtD
Mirabegron—Gastritis—Capecitabine—esophageal cancer	0.000485	0.0109	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000483	0.0109	CcSEcCtD
Mirabegron—Eye disorder—Cisplatin—esophageal cancer	0.00048	0.0108	CcSEcCtD
Mirabegron—Cardiac disorder—Cisplatin—esophageal cancer	0.000477	0.0108	CcSEcCtD
Mirabegron—Abdominal distension—Capecitabine—esophageal cancer	0.000477	0.0108	CcSEcCtD
Mirabegron—Influenza—Capecitabine—esophageal cancer	0.000473	0.0107	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00044	0.00993	CcSEcCtD
Mirabegron—Infestation—Capecitabine—esophageal cancer	0.000422	0.00952	CcSEcCtD
Mirabegron—Infestation NOS—Capecitabine—esophageal cancer	0.000422	0.00952	CcSEcCtD
Mirabegron—Vision blurred—Cisplatin—esophageal cancer	0.000422	0.00951	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000418	0.00944	CcSEcCtD
Mirabegron—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000416	0.00939	CcSEcCtD
Mirabegron—Urinary tract infection—Capecitabine—esophageal cancer	0.00041	0.00926	CcSEcCtD
Mirabegron—Osteoarthritis—Methotrexate—esophageal cancer	0.000408	0.0092	CcSEcCtD
Mirabegron—Rhinitis—Capecitabine—esophageal cancer	0.00038	0.00857	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000378	0.00853	CcSEcCtD
Mirabegron—Urinary tract disorder—Capecitabine—esophageal cancer	0.000374	0.00844	CcSEcCtD
Mirabegron—Connective tissue disorder—Capecitabine—esophageal cancer	0.000372	0.0084	CcSEcCtD
Mirabegron—Urethral disorder—Capecitabine—esophageal cancer	0.000371	0.00838	CcSEcCtD
Mirabegron—Breast disorder—Methotrexate—esophageal cancer	0.000368	0.00831	CcSEcCtD
Mirabegron—Infection—Cisplatin—esophageal cancer	0.000363	0.00818	CcSEcCtD
Mirabegron—Erythema multiforme—Capecitabine—esophageal cancer	0.000358	0.00808	CcSEcCtD
Mirabegron—Tachycardia—Cisplatin—esophageal cancer	0.000356	0.00804	CcSEcCtD
Mirabegron—Skin disorder—Cisplatin—esophageal cancer	0.000355	0.008	CcSEcCtD
Mirabegron—Eye disorder—Capecitabine—esophageal cancer	0.000354	0.00799	CcSEcCtD
Mirabegron—Cardiac disorder—Capecitabine—esophageal cancer	0.000352	0.00793	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000333	0.00751	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000327	0.00739	CcSEcCtD
Mirabegron—Back pain—Capecitabine—esophageal cancer	0.000319	0.0072	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000315	0.00711	CcSEcCtD
Mirabegron—Infestation NOS—Methotrexate—esophageal cancer	0.000314	0.00709	CcSEcCtD
Mirabegron—Infestation—Methotrexate—esophageal cancer	0.000314	0.00709	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000311	0.00703	CcSEcCtD
Mirabegron—Vision blurred—Capecitabine—esophageal cancer	0.000311	0.00701	CcSEcCtD
Mirabegron—Palpitations—Capecitabine—esophageal cancer	0.000291	0.00658	CcSEcCtD
Mirabegron—Hypertension—Capecitabine—esophageal cancer	0.000285	0.00642	CcSEcCtD
Mirabegron—Arthralgia—Capecitabine—esophageal cancer	0.000281	0.00633	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000279	0.00629	CcSEcCtD
Mirabegron—Urinary tract disorder—Methotrexate—esophageal cancer	0.000279	0.00628	CcSEcCtD
Mirabegron—Urethral disorder—Methotrexate—esophageal cancer	0.000276	0.00624	CcSEcCtD
Mirabegron—Dry mouth—Capecitabine—esophageal cancer	0.000275	0.0062	CcSEcCtD
Mirabegron—Infection—Capecitabine—esophageal cancer	0.000267	0.00603	CcSEcCtD
Mirabegron—Erythema multiforme—Methotrexate—esophageal cancer	0.000267	0.00602	CcSEcCtD
Mirabegron—Eye disorder—Methotrexate—esophageal cancer	0.000264	0.00595	CcSEcCtD
Mirabegron—Tachycardia—Capecitabine—esophageal cancer	0.000263	0.00593	CcSEcCtD
Mirabegron—Asthenia—Cisplatin—esophageal cancer	0.000262	0.00591	CcSEcCtD
Mirabegron—Cardiac disorder—Methotrexate—esophageal cancer	0.000262	0.00591	CcSEcCtD
Mirabegron—Skin disorder—Capecitabine—esophageal cancer	0.000261	0.0059	CcSEcCtD
Mirabegron—SLCO1A2—digestive system—esophageal cancer	0.000253	0.0486	CbGeAlD
Mirabegron—Diarrhoea—Cisplatin—esophageal cancer	0.00025	0.00564	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000245	0.00553	CcSEcCtD
Mirabegron—ORM1—lung—esophageal cancer	0.000239	0.0461	CbGeAlD
Mirabegron—Back pain—Methotrexate—esophageal cancer	0.000237	0.00536	CcSEcCtD
Mirabegron—Dyspepsia—Capecitabine—esophageal cancer	0.000237	0.00535	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000232	0.00524	CcSEcCtD
Mirabegron—Fatigue—Capecitabine—esophageal cancer	0.000232	0.00524	CcSEcCtD
Mirabegron—Vision blurred—Methotrexate—esophageal cancer	0.000231	0.00522	CcSEcCtD
Mirabegron—Rash—Cisplatin—esophageal cancer	0.00023	0.00519	CcSEcCtD
Mirabegron—Constipation—Capecitabine—esophageal cancer	0.00023	0.00519	CcSEcCtD
Mirabegron—Dermatitis—Cisplatin—esophageal cancer	0.00023	0.00519	CcSEcCtD
Mirabegron—BCHE—bronchus—esophageal cancer	0.00023	0.0443	CbGeAlD
Mirabegron—BCHE—smooth muscle tissue—esophageal cancer	0.000225	0.0433	CbGeAlD
Mirabegron—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00022	0.00497	CcSEcCtD
Mirabegron—Nausea—Cisplatin—esophageal cancer	0.000217	0.00489	CcSEcCtD
Mirabegron—Urticaria—Capecitabine—esophageal cancer	0.000214	0.00482	CcSEcCtD
Mirabegron—Abdominal pain—Capecitabine—esophageal cancer	0.000213	0.0048	CcSEcCtD
Mirabegron—SLCO1A2—lung—esophageal cancer	0.000211	0.0406	CbGeAlD
Mirabegron—Arthralgia—Methotrexate—esophageal cancer	0.000209	0.00472	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000208	0.00468	CcSEcCtD
Mirabegron—BCHE—trachea—esophageal cancer	0.000206	0.0397	CbGeAlD
Mirabegron—Infection—Methotrexate—esophageal cancer	0.000199	0.00449	CcSEcCtD
Mirabegron—Skin disorder—Methotrexate—esophageal cancer	0.000195	0.00439	CcSEcCtD
Mirabegron—Asthenia—Capecitabine—esophageal cancer	0.000193	0.00436	CcSEcCtD
Mirabegron—Pruritus—Capecitabine—esophageal cancer	0.00019	0.0043	CcSEcCtD
Mirabegron—Diarrhoea—Capecitabine—esophageal cancer	0.000184	0.00416	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000183	0.00412	CcSEcCtD
Mirabegron—Dizziness—Capecitabine—esophageal cancer	0.000178	0.00402	CcSEcCtD
Mirabegron—BCHE—digestive system—esophageal cancer	0.000178	0.0342	CbGeAlD
Mirabegron—Dyspepsia—Methotrexate—esophageal cancer	0.000176	0.00398	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000173	0.0039	CcSEcCtD
Mirabegron—Fatigue—Methotrexate—esophageal cancer	0.000173	0.0039	CcSEcCtD
Mirabegron—Rash—Capecitabine—esophageal cancer	0.00017	0.00383	CcSEcCtD
Mirabegron—Dermatitis—Capecitabine—esophageal cancer	0.00017	0.00383	CcSEcCtD
Mirabegron—Headache—Capecitabine—esophageal cancer	0.000169	0.0038	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000164	0.0037	CcSEcCtD
Mirabegron—ORM1—lymph node—esophageal cancer	0.000164	0.0315	CbGeAlD
Mirabegron—Nausea—Capecitabine—esophageal cancer	0.00016	0.00361	CcSEcCtD
Mirabegron—Urticaria—Methotrexate—esophageal cancer	0.000159	0.00359	CcSEcCtD
Mirabegron—Abdominal pain—Methotrexate—esophageal cancer	0.000158	0.00357	CcSEcCtD
Mirabegron—BCHE—lung—esophageal cancer	0.000148	0.0286	CbGeAlD
Mirabegron—Asthenia—Methotrexate—esophageal cancer	0.000144	0.00324	CcSEcCtD
Mirabegron—ALB—lymph node—esophageal cancer	0.000143	0.0276	CbGeAlD
Mirabegron—Pruritus—Methotrexate—esophageal cancer	0.000142	0.0032	CcSEcCtD
Mirabegron—Diarrhoea—Methotrexate—esophageal cancer	0.000137	0.00309	CcSEcCtD
Mirabegron—Dizziness—Methotrexate—esophageal cancer	0.000133	0.00299	CcSEcCtD
Mirabegron—Rash—Methotrexate—esophageal cancer	0.000126	0.00285	CcSEcCtD
Mirabegron—Dermatitis—Methotrexate—esophageal cancer	0.000126	0.00285	CcSEcCtD
Mirabegron—Headache—Methotrexate—esophageal cancer	0.000126	0.00283	CcSEcCtD
Mirabegron—CYP3A4—digestive system—esophageal cancer	0.00012	0.023	CbGeAlD
Mirabegron—Nausea—Methotrexate—esophageal cancer	0.000119	0.00269	CcSEcCtD
Mirabegron—CYP2D6—digestive system—esophageal cancer	0.000118	0.0226	CbGeAlD
Mirabegron—ABCB1—epithelium—esophageal cancer	0.000111	0.0214	CbGeAlD
Mirabegron—BCHE—lymph node—esophageal cancer	0.000101	0.0195	CbGeAlD
Mirabegron—ABCB1—trachea—esophageal cancer	9.84e-05	0.0189	CbGeAlD
Mirabegron—ABCB1—digestive system—esophageal cancer	8.46e-05	0.0163	CbGeAlD
Mirabegron—ABCB1—lung—esophageal cancer	7.07e-05	0.0136	CbGeAlD
Mirabegron—BCHE—Metabolism—CYP26A1—esophageal cancer	6.07e-05	0.000663	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	6.05e-05	0.00066	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GAPDH—esophageal cancer	5.94e-05	0.000648	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALOX15—esophageal cancer	5.92e-05	0.000646	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CRABP1—esophageal cancer	5.89e-05	0.000642	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.84e-05	0.000637	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	5.77e-05	0.000629	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CTNNA1—esophageal cancer	5.76e-05	0.000628	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC52A3—esophageal cancer	5.74e-05	0.000626	CbGpPWpGaD
Mirabegron—ALB—Metabolism—BLVRB—esophageal cancer	5.74e-05	0.000626	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL2—esophageal cancer	5.72e-05	0.000624	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	5.69e-05	0.00062	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTO1—esophageal cancer	5.65e-05	0.000616	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—TPI1—esophageal cancer	5.65e-05	0.000616	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.64e-05	0.000615	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GNG7—esophageal cancer	5.6e-05	0.000611	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—HSPA5—esophageal cancer	5.5e-05	0.0006	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALDOB—esophageal cancer	5.41e-05	0.000591	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PSME2—esophageal cancer	5.35e-05	0.000583	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PSME1—esophageal cancer	5.35e-05	0.000583	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ANXA1—esophageal cancer	5.32e-05	0.00058	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALDH2—esophageal cancer	5.25e-05	0.000572	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GAPDH—esophageal cancer	5.21e-05	0.000568	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SST—esophageal cancer	5.18e-05	0.000565	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CRABP1—esophageal cancer	5.16e-05	0.000563	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.13e-05	0.00056	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.12e-05	0.000558	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	5.06e-05	0.000552	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GHRL—esophageal cancer	5.04e-05	0.00055	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH3—esophageal cancer	5.04e-05	0.00055	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.04e-05	0.00055	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC52A3—esophageal cancer	5.03e-05	0.000549	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—BLVRB—esophageal cancer	5.03e-05	0.000549	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTT1—esophageal cancer	4.99e-05	0.000544	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FBXW7—esophageal cancer	4.96e-05	0.000541	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	4.93e-05	0.000538	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.91e-05	0.000536	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GNG7—esophageal cancer	4.91e-05	0.000536	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CA1—esophageal cancer	4.88e-05	0.000532	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC10A2—esophageal cancer	4.88e-05	0.000532	CbGpPWpGaD
Mirabegron—ABCB1—lymph node—esophageal cancer	4.83e-05	0.00931	CbGeAlD
Mirabegron—CYP2D6—Metabolism—SLC52A3—esophageal cancer	4.74e-05	0.000517	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—BLVRB—esophageal cancer	4.74e-05	0.000517	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ENO1—esophageal cancer	4.68e-05	0.00051	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS1—esophageal cancer	4.68e-05	0.00051	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.67e-05	0.00051	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PSME1—esophageal cancer	4.61e-05	0.000503	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PSME2—esophageal cancer	4.61e-05	0.000503	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALDH2—esophageal cancer	4.6e-05	0.000502	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH2—esophageal cancer	4.52e-05	0.000493	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CA2—esophageal cancer	4.46e-05	0.000487	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTT1—esophageal cancer	4.38e-05	0.000478	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.36e-05	0.000476	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.34e-05	0.000474	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP2A6—esophageal cancer	4.33e-05	0.000472	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.31e-05	0.00047	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CA1—esophageal cancer	4.28e-05	0.000466	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC10A2—esophageal cancer	4.28e-05	0.000466	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.22e-05	0.00046	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PLCE1—esophageal cancer	4.15e-05	0.000453	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADH7—esophageal cancer	4.15e-05	0.000453	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.13e-05	0.00045	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ENO1—esophageal cancer	4.1e-05	0.000448	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS1—esophageal cancer	4.1e-05	0.000448	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.1e-05	0.000447	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—ABL1—esophageal cancer	4.07e-05	0.000444	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PSME1—esophageal cancer	4.04e-05	0.000441	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PSME2—esophageal cancer	4.04e-05	0.000441	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC10A2—esophageal cancer	4.03e-05	0.00044	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CA1—esophageal cancer	4.03e-05	0.00044	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.02e-05	0.000439	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFBR2—esophageal cancer	4.01e-05	0.000438	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	3.98e-05	0.000434	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CA2—esophageal cancer	3.91e-05	0.000427	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SMAD4—esophageal cancer	3.8e-05	0.000414	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	3.74e-05	0.000408	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.73e-05	0.000407	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CA2—esophageal cancer	3.68e-05	0.000402	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADH1B—esophageal cancer	3.64e-05	0.000397	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADH7—esophageal cancer	3.64e-05	0.000397	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLCE1—esophageal cancer	3.64e-05	0.000397	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.61e-05	0.000393	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.56e-05	0.000388	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.53e-05	0.000385	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP1B1—esophageal cancer	3.49e-05	0.000381	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TYMP—esophageal cancer	3.48e-05	0.000379	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.43e-05	0.000374	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLCE1—esophageal cancer	3.43e-05	0.000374	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADH7—esophageal cancer	3.43e-05	0.000374	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.42e-05	0.000373	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—HMOX1—esophageal cancer	3.41e-05	0.000372	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP26A1—esophageal cancer	3.38e-05	0.000369	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.35e-05	0.000365	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALOX15—esophageal cancer	3.3e-05	0.00036	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP19A1—esophageal cancer	3.28e-05	0.000358	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ABCB1—esophageal cancer	3.27e-05	0.000357	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADH1B—esophageal cancer	3.19e-05	0.000348	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTO1—esophageal cancer	3.14e-05	0.000343	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TPI1—esophageal cancer	3.14e-05	0.000343	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.12e-05	0.00034	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HIF1A—esophageal cancer	3.11e-05	0.000339	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.1e-05	0.000338	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.1e-05	0.000338	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TYMP—esophageal cancer	3.05e-05	0.000332	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALDOB—esophageal cancer	3.01e-05	0.000329	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADH1B—esophageal cancer	3e-05	0.000328	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMOX1—esophageal cancer	2.99e-05	0.000327	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.99e-05	0.000326	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KDR—esophageal cancer	2.97e-05	0.000324	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.96e-05	0.000323	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS2—esophageal cancer	2.94e-05	0.00032	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.94e-05	0.00032	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.92e-05	0.000319	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GAPDH—esophageal cancer	2.9e-05	0.000317	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALOX15—esophageal cancer	2.89e-05	0.000315	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CRABP1—esophageal cancer	2.88e-05	0.000314	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ABCB1—esophageal cancer	2.87e-05	0.000313	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TYMP—esophageal cancer	2.87e-05	0.000313	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH1—esophageal cancer	2.8e-05	0.000305	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.79e-05	0.000305	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TPI1—esophageal cancer	2.76e-05	0.000301	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTO1—esophageal cancer	2.76e-05	0.000301	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GNG7—esophageal cancer	2.74e-05	0.000298	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.72e-05	0.000297	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDOB—esophageal cancer	2.64e-05	0.000288	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CREBBP—esophageal cancer	2.64e-05	0.000288	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.63e-05	0.000287	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CA1—esophageal cancer	2.63e-05	0.000287	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.6e-05	0.000283	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TPI1—esophageal cancer	2.6e-05	0.000283	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.58e-05	0.000281	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALDH2—esophageal cancer	2.56e-05	0.00028	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GAPDH—esophageal cancer	2.54e-05	0.000277	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CREBBP—esophageal cancer	2.54e-05	0.000277	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.54e-05	0.000277	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CRABP1—esophageal cancer	2.52e-05	0.000275	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—EGFR—esophageal cancer	2.49e-05	0.000272	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.49e-05	0.000272	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.48e-05	0.00027	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.46e-05	0.000268	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTT1—esophageal cancer	2.44e-05	0.000266	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2A6—esophageal cancer	2.41e-05	0.000263	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CA2—esophageal cancer	2.41e-05	0.000263	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.4e-05	0.000262	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GNG7—esophageal cancer	2.4e-05	0.000261	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.4e-05	0.000261	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CA—esophageal cancer	2.38e-05	0.00026	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.37e-05	0.000259	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS3—esophageal cancer	2.36e-05	0.000258	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ENO1—esophageal cancer	2.28e-05	0.000249	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS1—esophageal cancer	2.28e-05	0.000249	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.28e-05	0.000249	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOS3—esophageal cancer	2.27e-05	0.000248	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GNG7—esophageal cancer	2.26e-05	0.000246	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSME2—esophageal cancer	2.25e-05	0.000246	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSME1—esophageal cancer	2.25e-05	0.000246	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDH2—esophageal cancer	2.25e-05	0.000245	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.24e-05	0.000244	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADH7—esophageal cancer	2.24e-05	0.000244	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CREBBP—esophageal cancer	2.19e-05	0.000239	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.17e-05	0.000237	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CA—esophageal cancer	2.17e-05	0.000236	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTT1—esophageal cancer	2.14e-05	0.000233	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ERBB2—esophageal cancer	2.13e-05	0.000232	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.12e-05	0.000231	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.11e-05	0.00023	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.01e-05	0.00022	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ENO1—esophageal cancer	2e-05	0.000218	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS1—esophageal cancer	2e-05	0.000218	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2e-05	0.000218	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.99e-05	0.000217	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSME1—esophageal cancer	1.97e-05	0.000215	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSME2—esophageal cancer	1.97e-05	0.000215	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.97e-05	0.000214	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.96e-05	0.000214	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NOS3—esophageal cancer	1.96e-05	0.000214	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP1B1—esophageal cancer	1.94e-05	0.000212	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CREBBP—esophageal cancer	1.92e-05	0.000209	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.89e-05	0.000206	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ENO1—esophageal cancer	1.89e-05	0.000206	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCND1—esophageal cancer	1.88e-05	0.000205	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TYMP—esophageal cancer	1.88e-05	0.000205	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSME2—esophageal cancer	1.86e-05	0.000203	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSME1—esophageal cancer	1.86e-05	0.000203	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP19A1—esophageal cancer	1.83e-05	0.000199	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.83e-05	0.000199	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1A—esophageal cancer	1.82e-05	0.000198	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—EP300—esophageal cancer	1.8e-05	0.000196	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—esophageal cancer	1.79e-05	0.000195	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.78e-05	0.000194	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EP300—esophageal cancer	1.73e-05	0.000189	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NOS3—esophageal cancer	1.72e-05	0.000188	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.7e-05	0.000186	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TPI1—esophageal cancer	1.7e-05	0.000185	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.7e-05	0.000185	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—esophageal cancer	1.67e-05	0.000182	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.64e-05	0.000178	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.63e-05	0.000178	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.6e-05	0.000175	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.6e-05	0.000175	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCB1—esophageal cancer	1.6e-05	0.000175	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—esophageal cancer	1.57e-05	0.000172	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.57e-05	0.000171	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.55e-05	0.000169	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.51e-05	0.000165	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MYC—esophageal cancer	1.51e-05	0.000164	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—EP300—esophageal cancer	1.49e-05	0.000163	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GNG7—esophageal cancer	1.48e-05	0.000161	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGFR—esophageal cancer	1.47e-05	0.000161	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—esophageal cancer	1.46e-05	0.000159	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.38e-05	0.000151	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.38e-05	0.00015	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CA—esophageal cancer	1.33e-05	0.000145	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.32e-05	0.000144	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.32e-05	0.000144	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—EP300—esophageal cancer	1.31e-05	0.000143	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.3e-05	0.000142	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—esophageal cancer	1.29e-05	0.00014	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CA—esophageal cancer	1.28e-05	0.00014	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—esophageal cancer	1.24e-05	0.000135	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.23e-05	0.000135	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ENO1—esophageal cancer	1.23e-05	0.000135	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSME2—esophageal cancer	1.22e-05	0.000133	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSME1—esophageal cancer	1.22e-05	0.000133	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.21e-05	0.000132	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	1.1e-05	0.00012	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CREBBP—esophageal cancer	1.07e-05	0.000117	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.05e-05	0.000114	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.86e-06	0.000108	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CA—esophageal cancer	9.67e-06	0.000106	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NOS3—esophageal cancer	9.57e-06	0.000104	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CREBBP—esophageal cancer	9.37e-06	0.000102	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—esophageal cancer	9e-06	9.82e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CREBBP—esophageal cancer	8.83e-06	9.63e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—esophageal cancer	8.76e-06	9.55e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.64e-06	9.42e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NOS3—esophageal cancer	8.39e-06	9.15e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NOS3—esophageal cancer	7.9e-06	8.62e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—esophageal cancer	7.67e-06	8.37e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—EP300—esophageal cancer	7.28e-06	7.94e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—esophageal cancer	7.23e-06	7.89e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—EP300—esophageal cancer	6.38e-06	6.96e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—EP300—esophageal cancer	6.01e-06	6.56e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.77e-06	6.3e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CA—esophageal cancer	5.39e-06	5.88e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NOS3—esophageal cancer	5.17e-06	5.64e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.73e-06	5.16e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.72e-06	5.15e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.45e-06	4.85e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—EP300—esophageal cancer	3.93e-06	4.29e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.91e-06	3.17e-05	CbGpPWpGaD
